{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:37:32Z","timestamp":1790181452777,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"the National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2017R1C1B5018180"],"award-info":[{"award-number":["2017R1C1B5018180"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Keimyung University Research Grant of 2016"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10620-018-4963-1","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T08:52:04Z","timestamp":1519635124000},"page":"2474-2479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Procalcitonin as a Decision-Supporting Marker of Urgent Biliary Decompression in Acute Cholangitis"],"prefix":"10.1007","volume":"63","author":[{"given":"Yoon Suk","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Bum","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Yup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"4963_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.chest.2016.04.010","volume":"150","author":"WH Self","year":"2016","unstructured":"Self WH, Grijalva CG, Williams DJ, et al. Procalcitonin as an early marker of the need for invasive respiratory or vasopressor support in adults with community-acquired pneumonia. Chest. 2016;150:819\u2013828.","journal-title":"Chest"},{"key":"4963_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00534-012-0563-1","volume":"20","author":"F Miura","year":"2013","unstructured":"Miura F, Takada T, Strasberg SM, et al. TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013;20:47\u201354.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"4963_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","volume":"341","author":"M Assicot","year":"1993","unstructured":"Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515\u2013518.","journal-title":"Lancet"},{"key":"4963_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2013.697","volume":"309","author":"P Schuetz","year":"2013","unstructured":"Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA. 2013;309:717\u2013718.","journal-title":"JAMA"},{"key":"4963_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.annemergmed.2012.05.027","volume":"60","author":"CH Yo","year":"2012","unstructured":"Yo CH, Hsieh PS, Lee SH, et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. Ann Emerg Med. 2012;60:591\u2013600.","journal-title":"Ann Emerg Med"},{"key":"4963_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/infdis\/jit579","volume":"209","author":"DM Musher","year":"2014","unstructured":"Musher DM, Bebko SP, Roig IL. Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection. J Infect Dis. 2014;209:631\u2013633.","journal-title":"J Infect Dis"},{"key":"4963_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S2213-2600(16)30383-6","volume":"4","author":"MS Niederman","year":"2016","unstructured":"Niederman MS. Serum procalcitonin and the admission decision in CAP. Lancet Respir Med. 2016;4:956.","journal-title":"Lancet Respir Med"},{"key":"4963_CR8","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1378\/chest.128.4.2223","volume":"128","author":"M Masia","year":"2005","unstructured":"Masia M, Gutierrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest. 2005;128:2223\u20132229.","journal-title":"Chest"},{"key":"4963_CR9","first-page":"48-58.e42","volume":"52","author":"DT Huang","year":"2008","unstructured":"Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008;52:48-58.e42.","journal-title":"Ann Emerg Med"},{"key":"4963_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ajem.2011.08.009","volume":"30","author":"JH Park","year":"2012","unstructured":"Park JH, Wee JH, Choi SP, Oh SH. The value of procalcitonin level in community-acquired pneumonia in the ED. Am J Emerg Med. 2012;30:1248\u20131254.","journal-title":"Am J Emerg Med"},{"key":"4963_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E Jong de","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819\u2013827.","journal-title":"Lancet Infect Dis"},{"key":"4963_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1473-3099(16)30150-5","volume":"16","author":"RM Dorizzi","year":"2016","unstructured":"Dorizzi RM, Azzini AM, Sette P. Procalcitonin to guide antibiotic stewardship in intensive care. Lancet Infect Dis. 2016;16:889.","journal-title":"Lancet Infect Dis"},{"key":"4963_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1373\/clinchem.2017.272294","volume":"63","author":"AWS Fung","year":"2017","unstructured":"Fung AWS, Beriault D, Diamandis EP, et al. The role of procalcitonin in diagnosis of sepsis and antibiotic stewardship: opportunities and challenges. Clin Chem. 2017;63:1436\u20131441.","journal-title":"Clin Chem"},{"key":"4963_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0924-8579(02)00047-X","volume":"20","author":"ED Carrol","year":"2002","unstructured":"Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002;20:1\u20139.","journal-title":"Int J Antimicrob Agents"},{"key":"4963_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40560-017-0246-8","volume":"5","author":"AL Vijayan","year":"2017","unstructured":"Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.","journal-title":"J Intensive Care"},{"key":"4963_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/jhbp.132","volume":"21","author":"S Shinya","year":"2014","unstructured":"Shinya S, Sasaki T, Yamashita Y, et al. Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. J Hepatobiliary Pancreat Sci. 2014;21:777\u2013785.","journal-title":"J Hepatobiliary Pancreat Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-4963-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-4963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-4963-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T19:32:00Z","timestamp":1551123120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-4963-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4963"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-4963-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"4 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}